Anacetrapib 100mg 100mg | Purity Not Available
Adooq Bioscience
Anacetrapib (MK-0859) is a CETP inhibitor being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.
More Information Supplier PageAnacetrapib (MK-0859) is a CETP inhibitor being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.
More Information Supplier PageAnacetrapib (MK-0859) is a CETP inhibitor being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageCHIR-98014 is a very potent, selective, cell-permeable reversible inhibitor of GSK-3.
More Information Supplier PageCHIR-98014 is a very potent, selective, cell-permeable reversible inhibitor of GSK-3.
More Information Supplier PageARQ-197 is a selective inhibitor of the c-Met receptor tyrosine kinase
More Information Supplier PageARQ-197 is a selective inhibitor of the c-Met receptor tyrosine kinase
More Information Supplier Page